Cargando…

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations

Detalles Bibliográficos
Autores principales:	Kleebayoon, Amnuay, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Formosan Medical Association, Elsevier 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800810/ https://www.ncbi.nlm.nih.gov/pubmed/36610888 http://dx.doi.org/10.1016/j.jfma.2022.12.018

Ejemplares similares

Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Gadolinium changes detected on cardiovascular magnetic resonance imaging following COVID-19 vaccine-related myocarditis in adolescents
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence: Clinical Course of Adverse Effects after COVID-19 Vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccines and increased blood pressure
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
por: Mungmunpuntipantip, Rujititka, et al.
Publicado: (2023)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination status and related process of care outcomes
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute myocarditis after administration of COVID-19 vaccine: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on the evaluation of patients with COVID-19 vaccine side effects
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Covid‐19 vaccination landscape in Malta through social media: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute interstitial nephritis following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Factors affecting intention of COVID‐19 preventive behaviours including vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on “Effect of female COVID-19 vaccination on assisted reproductive outcomes: a systematic review and meta-analysis”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on the effectiveness of four SARS-COV-2 vaccines
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

“Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report”: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment: Post COVID-19 Vaccination Encephalitis as a Cause of Subacute Progressive Dementia: A Case Report and Literature Review
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Assessment of psychological distress & COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Vaccination rates, perceptions, and information sources in inflammatory arthritis: Comment on the article by Lyon et al
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Gastrointestinal System Involvement in COVID
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Kratom (Mitragyna speciosa) and COVID-19: How about the current evidence?
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Hesitancy toward vaccination against COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Competition between variants and SARS-Co-V2 epidemic, from Wuhan to XBB.1.16.: Natural selection?
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Authorship Policy and ChatGPT
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s3mid7t0tu2g6j33bjlbekmmat